Is nonadmission-based care for TIA patients cost-effective? A microcosting study

Lauren Maree Sanders, Dominique Ann-Michelle Cadilhac, Velandai Srikanth, Chia Pei Chong, Thanh G Phan

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


SUMMARY We previously demonstrated the safety and effectiveness of a nonadmission-based model for TIA care (Monash TIA Triaging Treatment [M3T]). In this microcosting study, we used a pre?post cohort design with multivariable uncertainty analyses to compare actual resource utilization costs between M3T (years 2004?2007) and the previous admission-based model (2003). Average total episode costs per patient were significantly less for M3T (Australian dollars [AUD] 1,927.00, 95 confidence interval [CI] AUD 1,829.00?1,037.00) compared with the admission-based model (AUD 4,841.00, 95 CI AUD 4,178.00?5,590.00). Nonadmission care in M3T was substantially cost-saving with a median 3 (95 uncertainty interval 0.7?6.0) additional strokes averted per 100 patients treated, based on an observed 90-day stroke rate of 1.50 (95 CI 0.73 ?3.05 ) and 4.67 (95 CI 2.28 ?9.32 ) in the admission-based model.
Original languageEnglish
Pages (from-to)58 - 66
Number of pages9
JournalNeurology: Clinical Practice
Issue number1
Publication statusPublished - 2015

Cite this